RISEDRONATE BGR 75 mg, film-coated tablet 6 tablets
Active ingredients: Risedronic acid, Risedronate sodium hemi-pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISEDRONATE BGR 75 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 6 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Jul 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67902118CIP72698430CIP133400926984304Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISÉDRONATE MONOSODIQUEcomprimé | 75 mg · un comprimé | SA |
| ACIDE RISÉDRONIQUEcomprimé | 69,6 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.